Medicines May Soon Come with Braille Labels, Audio QR Codes

New Delhi: India’s drug regulatory authority is considering having braille cards and voice-assisted QR codes on medicine strips to make them patient friendly. The regulatory body has invited public comments for further action.

Earlier, the regulatory body had received representations regarding problems being faced by blind or visually impaired people to read medicines, tablet/capsule strips.

“These special peoples face difficulty to know the name and expiry of the medicines and depend on others therefore, it was requested that a provision under Drugs and Cosmetics Act and Rules to label the drugs with braille inscriptions be inserted,” people in the know told ET.

The matter was then deliberated by the Drugs Consultative Committee (DCC) meeting in 2020 which recommended constituting a sub- committee to examine the issue in detail for further consideration.

The sub-committee which was constituted on DCC’s recommendation had submitted its report, recommending support in the ease of access of medication to the visually impaired persons, the guideline regarding additional labelling in braille language was proposed to be implemented “initially on voluntary basis” for the drugs, which are supplied in mono carton pack size.

It was also recommended that consideration should be given to medicinal products likely to be used by a high visually impaired target population, e.g. certain eye drop preparations.

It was also advised that the braille labels would not be applicable for the products dispensed or given under supervision of health care professional’s e.g. injectable, vaccine etc.

Related Posts

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Food regulator FSSAI on Friday said it has suspended the licence of Punjab-based Rehaan Healthcare after it found serious violations of rules at the company’s health supplements and nutraceuticals manufacturing…

Pharma companies in a flux over Trump’s 200% tariff move on generics

India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty